Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
2018
How WHO’s Internship Policy Became More Inclusive
Onze collega gaat terug naar (Utrecht Summer) School
A Week of Promise for Access to Medicines
What Role Can Civil Society Play in the European Regulatory Process?
Staff Spotlight: Evelien Colenberg
2017
Staff Spotlight: Gemma Buckland-Merrett
2016
Intern Spotlight: A Year in Review
Intern Spotlight: Huibert-Jan Joosse
Intern Spotlight: Gaby Ooms
Intern Spotlight: Linnea Celik
Intern Spotlight: Brian Tielrooij
Intern Spotlight: Anneke Johnson
November is ‘Intern Spotlight Month’ at Health Action International
Next Gen Advocates Excel at HAI/HP4L Summer School on Access to Medicines
2015
HAI Holds Workshops on EU Medicines Policy & Access to Medicines in Eastern Europe
World Health Assembly Executive Board 136: YP-CDN, NWIA and HAI intervention on the WHO’s internship programme
2014
Student Stop AIDS National Gathering an inspiring start to Access to Medicines Week
Abysmal decisions: Why the EC’s medicinal units shouldn’t be moved to DG Industry
World Health Assembly: HAI and ARC intervention on antimicrobial resistance, including antibiotic resistance
World Health Assembly 67: HAI intervention on the WHO's framework of engagement with non-state actors
A new (and improved) model to regulate pharmaceutical promotion
Enhancing accountability in the medicines market: The Medicines Transparency Alliance
2011
Statement on Medicines Patent Pool
DG Trade State of Play reveals EU's ambitions for IP protection in FTAs
Conflicts of Interest and the Future of Financing for WHO.
DG Trade public hearing on the “Protection and enforcement of IPR in third countries
Foundations: Conlicts of interests and Democracy issues
Corporate funding linked to EU patient & consumer groups policy
2010